← back to search

Hong Shen

Jiangsu University · CN
Area of research
Oncology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, Pharmacogenetics and Drug Metabolism, and Liver Disease Diagnosis and Treatment.
h-index
38
citations
3,903
works
155
NIH funding
primary concept
email

Recent publications

Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studies
Drug Metabolism and Disposition 2026cited by 0position: contributordoi
Membrane transporters in drug development and as determinants of precision medicine
Nature Reviews Drug Discovery 2024cited by 206position: middledoi
Variety of rumen microbial populations involved in biohydrogenation related to individual milk fat percentage of dairy cows
Frontiers in Veterinary Science 2023cited by 11position: middledoi
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)
Frontiers in Oncology 2023cited by 8position: middledoi
Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome.
2023cited by 8position: contributordoi
Recent advances in the in vitro and in vivo methods to assess impact of P-glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition.
2023cited by 6position: contributordoi
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
2023cited by 5position: contributordoi
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Acta Pharmaceutica Sinica B 2022cited by 140position: middledoi
Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults
Frontiers in Nutrition 2021cited by 40position: middledoi
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Molecular Cell 2020cited by 151position: middledoi
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug–Drug Interaction and Associated Biomarker Levels in Healthy Volunteers
Clinical and Translational Science 2019cited by 69position: middledoi
Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
2019cited by 18position: contributordoi
Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
2019cited by 9position: contributordoi
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium
Clinical Pharmacology & Therapeutics 2018cited by 198position: middledoi
Structural and Functional Impacts of ER Coactivator Sequential Recruitment
Molecular Cell 2017cited by 107position: middledoi

Grants

CIVIC-FA Track B: Strengthening Peer-Run Safety-Net Behavioral Health Services through Community-centered AI Design
NSF2527408$700,0002025–2026PIRePORTER
SCC-CIVIC-PG Track B: Strengthening Peer-Run Community Mental Health Services for Marginalized Population through Participatory AI Design
NSF2431230$75,0002024–2025PIRePORTER
CAREER: Microenvironment pH controllers: regulating the endocytosis pathway
NSF0748285$402,0002008–2013PIRePORTER

Frequent collaborators

· 6 papers (2019–2026)Yurong Lai · University of Connecticut4 papers (2018–2024)Kathleen M. Giacomini · University of California, San Francisco3 papers (2018–2024)Xiaoyan Chu · University of Manchester3 papers (2018–2024)Sook Wah Yee · Pfizer (United States)2 papers (2019–2024)Steven J. Ludtke · Baylor College of Medicine2 papers (2017–2020)Charles E. Foulds · Baylor College of Medicine2 papers (2017–2020)Bert W. O’Malley · Children's Cancer Center2 papers (2017–2020)Aleksandra Galetin · University of Manchester2 papers (2018–2024)Kenta Yoshida · Gene Therapy Laboratory2 papers (2018–2024)Zhao Wang · Baylor College of Medicine2 papers (2017–2020)Ping Yi · Wuhan Science and Technology Bureau2 papers (2017–2020)Maciej J. Zamek‐Gliszczynski · University of Manchester2 papers (2018–2024) · 1 papers (2018–2018)Imad Hanna · University of Connecticut1 papers (2018–2018)Grigore Pintilie · Palo Alto University1 papers (2017–2017)Marilyn M. Giacomini · Gilead Sciences (United States)1 papers (2019–2019)Jiyou Zhang · Nanjing Agricultural University1 papers (2023–2023)Donald Tweedie · University of Kentucky1 papers (2024–2024)Yuichi Sugiyama · Yokohama City University1 papers (2018–2018)